Review
References
|
Aguilar JC, Rodríguez EG (2007). Vaccine adjuvants revisited. Vaccine 25:3752-3762. Crossref |
||||
|
Basu N, Rastogi RP (1967). Triterpenoid saponins and sapogenins. Phytochemistry 6(9):1249-1270. Crossref |
||||
|
Cox JC, Coulter AR (1997). Adjuvants - a classification and review of their modes of action. Vaccine 15(3):248-256. Crossref |
||||
|
Da Silva BP, Soares JBRC, De Souza EP, Palatnik M, De Souza CBP, Parente JP (2005). Pulcherrimasaponin from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis. Vaccine 23(8):1061-1071. Crossref |
||||
|
Dzierzbicka K, KoÅ‚odziejczyk A (2006). Adjuvants – essential components of new generation vaccines. Post. Biochem. 52(2):204-211. Pubmed |
||||
| Dzierzbicka K, KoÅ‚odziejczyk AM (2003). Muramyl peptides – synthesis and biological activity. Polym. J. Chem. 77(4):373-395. | ||||
|
Dzierzbicka K, Wardowska A, Rogalska M, Trzonkowski P (2012). New conjugates of muramyl dipeptide and nor-muramyl dipeptide linked to tuftsin and retro-tuftsin derivative significantly influence their biological activity. Pharmacol. Rep. 64(1): 217-223. Crossref |
||||
|
Dzierzbicka K, Wardowska A, Trzonkowski P (2011). Recent developments in the synthesis and biological activity of muramylpeptides. Curr. Med. Chem. 18(16)2438-2451. Crossref |
||||
|
Gupta RK, Siber GR (1995). Adjuvants for human vaccines – current status, problems and future prospects. Vaccine 13(14): 1263-1276. Crossref |
||||
|
Kensil CR, Patel U, Lennick M, Marciani D (1991). Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146(2):431-437. Pubmed |
||||
|
Lacaille-Dubois MA, Wagner H (1996). A review of the biological and pharmacological activities of saponins. Phytomedicine 2(4):363-386. Crossref |
||||
|
Mahato SB, Nandy AK (1991). Triterpenoid saponins discovered between 1987 and 1989. Phytochemistry 30(5):1357-1390. Crossref |
||||
|
Marciani DJ (2003). Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov. Today 8(20):934-943. Crossref |
||||
|
Milgate J, Roberts DCK (1995). The nutritional and Biological significance of saponins. Nutr. Res. 15(8):1223-1249. Crossref |
||||
| Mota EF, Lima MGS, De Melo DF (2006). Adjuvantes imunológicos: avanços e perspectivas. Ciên. Anim. 16(2):79-88. | ||||
|
Nico D, Santos FN, Borja-Cabrera GP, Palatnik M, Palatnik De Souza CB (2007). Assessment of the monoterpene, glycidic and triterpene-moieties contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth. during vaccination agaisnt experimental visceral leishmaniasis. Vaccine 25(4):649-658. Crossref |
||||
|
Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T, Yoshikawa M (2000). Adjuvant and haemolytic activities of saponins derived from medicinal and food plants. Biol. Chem. 381:67–74. Crossref |
||||
|
Osbourn A (1996). Saponins and plant defence- a soap story. Trends Plant Sci. 1(1):4-9. Crossref |
||||
|
Pearse MJ, Drane D (2004). ISCOMATRIXTM adjuvant: a potent inducer of humoral and cellular immune responses. Vaccine 22(19): 2391-2395. Crossref |
||||
| Resende FCB, Passold J, Ferreira SIAC, Zanetti CR, Lima HC (2004). Adjuvantes de vacinas: possibilidades de uso em seres humanos ou animais. Rev. Bras. Alergia Immunopatol. 27(3): 116-124. | ||||
|
Samsel M, Dzierzbicka K, Trzonkowski P (2014). Synthesis and antiproliferative activity of conjugates of adenosine with muramyl dipeptide and nor-muramyl dipeptide derivatives. Bioorg. Med. Chem. Lett. 24:3587-3591. Crossref |
||||
|
Santos WR, Bernado RR, Peçanha LMT, Palatnik M, Parente JP, De Souza CBP (1997). Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani. Vaccine 15(9): 1024-1029. Crossref |
||||
| Simões CMO, Schenkel EP, Gosmman G, de Mello JCP, Mentz L, Petrovick PR (2010). Farmacognosia da Planta ao Medicamento. Porto Alegre / Florianópolis: Editora Da UFRGS / Editora da UFSC. | ||||
|
Skene CD, Sutton P (2006). Saponin- adjuvanted particulate vaccines for clinical use. Methods 40(1): 53-59. Crossref |
||||
|
Sparg SG, LighT ME, Staden JV (2004). Biological activities and distribution of plant saponins. J. Ethnopharmacol. 94(2): 219-243. Crossref |
||||
|
Sun HX, Xie Y, Ye YP (2009). Advances in saponin – based adjuvants. Vaccine 27(12):1787-1796. Crossref |
||||
|
Takechi M, Shimada S, Tanaka Y (1992). Time course and inhibition of saponin-induced hemolysis. Planta Med. 58(2):128-130. Crossref |
||||
|
Vogel FR (1995). The role of adjuvants in retroviral vaccines. Int. J. Immunopharmacol. 17(2):85-90. Crossref |
||||
|
Wardowska A, Dzierzbicka K, Szaryńska M, Dąbrowska-Szponar M, Wiśniewska K, Myśliwski A, Trzonkowski P (2009). Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis. Vaccine 27(3):369-374. Crossref |
||||
|
Wardowska A, Dzierzbicka K, Trzonkowski P, Myśliwski A (2006). Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe). Int. Immunopharmacol. 6(10): 1560-1568. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
